{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:50:45Z","timestamp":1790481045857,"version":"4.1.0"},"reference-count":42,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>INTRODU\u00c3\u2021\u00c3\u0192O: O arsenal terap\u00c3\u00aautico contra a leishmaniose tegumentar \u00c3\u00a9 muito restrito. Os antimoniais pentavalentes permanecem como as drogas de escolha para seu tratamento h\u00c3\u00a1 mais de 50 anos. Apesar da sua efic\u00c3\u00a1cia, necessita de inje\u00c3\u00a7\u00c3\u00b5es di\u00c3\u00a1rias, apresenta muitos efeitos colaterais e tempo de cura prolongado. OBJETIVO: Realizar uma revis\u00c3\u00a3o sistem\u00c3\u00a1tica da literatura sobre os avan\u00c3\u00a7os no tratamento da leishmaniose tegumentar do novo mundo nos \u00c3\u00baltimos dez anos. METODOLOGIA: Realizou-se em junho de 2009 uma busca eletr\u00c3\u00b4nica nas bases de dados Pubmed, LILACS e na biblioteca eletr\u00c3\u00b4nica Scielo. As palavras de busca em ingl\u00c3\u00aas foram: \"cutaneous\", \"leishmaniasis\" e \"treatment\". Foram inclu\u00c3dos apenas ensaios cl\u00c3nicos randomizados, duplo-cegos, placebo controlados. Utilizou-se a escala de Jadad para avaliar a qualidade dos estudos selecionados. RESULTADOS: Segundo os crit\u00c3\u00a9rios de inclus\u00c3\u00a3o e exclus\u00c3\u00a3o, apenas 8 artigos foram selecionados. As drogas avaliadas nos estudos selecionados foram Glucantime\u00c2\u00ae, miltefosine, imunoterapia, imiquimod, rhGM-CSF, pentoxifilina e paramomicina. CONCLUS\u00c3\u0192O: Apesar de a leishmaniose tegumentar ser um importante problema de sa\u00c3\u00bade p\u00c3\u00bablica, os dados publicados sobre o uso de novas drogas para o tratamento da leishmaniose tegumentar em nosso meio ainda s\u00c3\u00a3o bastante limitados<\/jats:p>","DOI":"10.1590\/s0365-05962011000300012","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T16:36:38Z","timestamp":1309451798000},"page":"497-506","source":"Crossref","is-referenced-by-count":37,"title":["Avan\u00e7os no tratamento da leishmaniose tegumentar do novo mundo nos \u00faltimos dez anos: uma revis\u00e3o sistem\u00e1tica da literatura"],"prefix":"10.1590","volume":"86","author":[{"given":"Olga Laura Sena","family":"Almeida","sequence":"first","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussamara Brito","family":"Santos","sequence":"additional","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Manual de Controle da Leishmaniose Tegumentar Americana","first-page":"7","year":"2000"},{"key":"ref2","series-title":"Dermatologia","first-page":"755","author":"Sampaio SAP","year":"2008","edition":"3"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis","volume":"19","author":"Nassiri-Kashani M","year":"2005","journal-title":"J Eur Acad Dermatol Venereol","ISSN":"https:\/\/id.crossref.org\/issn\/0926-9959","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","article-title":"Cytokine profile and pathology in human leishmaniasis","volume":"31","author":"Ribeiro-de-Jesus A","year":"1998","journal-title":"Braz J Med Biol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho EM","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref6","first-page":"113","article-title":"Estudo cl\u00c3nico da leishmaniose tegumentar americana","volume":"1","author":"Aguiar Pupo JA","year":"1946","journal-title":"Rev Hosp Clin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman JD","year":"1997","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0022-3859.927","article-title":"Recent advances in the diagnosis of leishmaniasis","volume":"49","author":"Singh S","year":"2003","journal-title":"J Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3859","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial","volume":"41","author":"Machado-Pinto J","year":"2002","journal-title":"Int J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962007000200002","article-title":"Tratamento da Leishmaniose Tegumentar Americana","volume":"82","author":"Lima EB","year":"2007","journal-title":"An. Bras. Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0365-0596","issn-type":"print"},{"key":"ref11","first-page":"35","article-title":"Morte s\u00c3\u00babita causada por Glucantime","volume":"63","author":"Sampaio RNR","year":"1988","journal-title":"An Bras Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0365-0596","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR","year":"1996","journal-title":"Control Clin Trials","ISSN":"https:\/\/id.crossref.org\/issn\/0197-2456","issn-type":"print"},{"key":"ref13","series-title":"Farmacologia","first-page":"687","author":"Silva P","year":"2006","edition":"7"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann G","year":"2002","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocoline: oral treatment of visceral Leishmaniasis in mice","volume":"36","author":"Kuhlencord A","year":"1992","journal-title":"Antimicrob Agents Chemoter"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto J","year":"2004","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts: HPV Study Group. Human PapillomaVirus","volume":"134","author":"Edwards L","year":"1998","journal-title":"Arch Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-987X","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg ML","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates S","year":"1999","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Ver\u00c3\u00a1stegui C","year":"2005","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02990842","article-title":"The effect of granulocyte-macrophage colony-stimulating factor (rGM-CSF) on macrophage function in microbial disease","volume":"13","author":"Jones TC","year":"1996","journal-title":"Med Oncol","ISSN":"https:\/\/id.crossref.org\/issn\/1357-0560","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1086\/315082","article-title":"Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis","volume":"180","author":"Almeida R","year":"1999","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"Santos JB","year":"2004","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1365-3156.2003.01087.x","article-title":"Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults","volume":"8","author":"Das BK","year":"2003","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado PR","year":"2007","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, doubleblind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus ethylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana BA","year":"2001","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref27","series-title":"Epidemiologia cl\u00c3nica: como realizar pesquisa cl\u00c3nica na pr\u00c3\u00a1tica","first-page":"31","author":"Haynes RB","year":"2008","edition":"3"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0169-4758(94)90398-0","article-title":"Medicinal plants in the fight against leishmaniasis","volume":"10","author":"Iwu MM","year":"1994","journal-title":"Parasitol Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4758","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/S0037-86821985000300011","article-title":"Pentavalent antimonials: Old drugs for new diseases","volume":"18","author":"Marsden P","year":"1985","journal-title":"Rev Soc Brasil Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","article-title":"Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-g in treating cutaneous leishmaniasis in Guatemala","volume":"18","author":"Arana BA","year":"1994","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto J","year":"2008","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1590\/S1415-790X2004000300010","article-title":"Leishmaniose tegumentar americana: hist\u00c3\u00b3rico, epidemiologia e perspectivas de controle","volume":"7","author":"Basano AS","year":"2004","journal-title":"Rev Bras Epidemiol"},{"key":"ref33","series-title":"Efeito do GM-CSF na Leishmaniose Cut\u00c3\u00a2nea: Aspectos Cl\u00c3nicos, Terap\u00c3\u00aauticos e Imunol\u00c3\u00b3gicos","author":"Santos JB"},{"key":"ref34","series-title":"Avalia\u00c3\u00a7\u00c3\u00a3o da Efic\u00c3\u00a1cia e Mecanismos Imunol\u00c3\u00b3gicos do rhGM-CSF como Adjuvante no Tratamento da Leishmaniose Tegumentar","author":"Santos JB"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/156.1.73","article-title":"Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis","volume":"156","author":"Jones TC","year":"1987","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref36","first-page":"975","article-title":"Immunopathological aspects of mucocutaneous leishmaniasis","volume":"71","author":"Bittencourt AL","year":"1967","journal-title":"Hospital","ISSN":"https:\/\/id.crossref.org\/issn\/0018-5469","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez C","year":"1993","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th-1 responses in mucosal leishmaniais patients","volume":"70","author":"Bacellar O","year":"2002","journal-title":"Infect Immun","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","article-title":"Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline","volume":"155","author":"Strieter RM","year":"1988","journal-title":"Biochem Biophys Res Commun","ISSN":"https:\/\/id.crossref.org\/issn\/0006-291X","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0074-02762000000400006","article-title":"Action of Pentoxifylline on Experimental Cutaneous Leishmaniasis Due to Leishmania (Leishmania) amazonensis","volume":"95","author":"de S\u00c3\u00a1 Oliveira T","year":"2000","journal-title":"Mem Inst Oswaldo Cruz","ISSN":"https:\/\/id.crossref.org\/issn\/0074-0276","issn-type":"print"},{"key":"ref41","series-title":"Epidemiologia Cl\u00c3nica","author":"Greenberg RS","year":"2005","edition":"3"},{"key":"ref42","series-title":"Epidemiologia Cl\u00c3nica: Elementos Essenciais","first-page":"170","author":"Fletcher RH","year":"2006","edition":"4"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v86n3\/v86n3a12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:40Z","timestamp":1747666840000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962011000300012&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0365-05962011000300012"],"URL":"https:\/\/doi.org\/10.1590\/s0365-05962011000300012","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}